Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Aug 16;70(8):e20240322.
doi: 10.1590/1806-9282.20240322. eCollection 2024.

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Mohammad Amin Akbarzadeh  1 , Yosra Vaez-Gharamaleki  2 , Farid Jahanshahlou  3 , Alireza Ghaffari Bavil  4 , Sina Hamzehzadeh  5   6 , Sina Seifimansour  7 , Alireza Rahimi-Mamaghani  8 , Mohammad-Salar Hosseini  1   2   3   8
Affiliations
Meta-Analysis

Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

Mohammad Amin Akbarzadeh et al. Rev Assoc Med Bras (1992). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis flow diagram of the study.
Figure 2
Figure 2. Pooled analysis for risk of mortality (a) and hospitalization (b) in chronic lymphocytic leukemia patients with COVID-19 infection.
See this image and copyright information in PMC

References

    1. Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148(148):211–212. doi: 10.1016/j.radonc.2020.04.041. - DOI - PMC - PubMed
    1. Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, et al. Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia. Front Immunol. 2020;11:594556–594556. doi: 10.3389/fimmu.2020.594556. - DOI - PMC - PubMed
    1. Vitale C, Boccellato E, Comba L, Jones R, Perutelli F, Griggio V, et al. Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia. Cancers (Basel) 2021;13(15):3856–3856. doi: 10.3390/cancers13153856. - DOI - PMC - PubMed
    1. Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, et al. Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma. 2018;59(3):625–632. doi: 10.1080/10428194.2017.1347931. - DOI - PubMed
    1. Hosseini M-S, Jahanshahlou F, Akbarzadeh MA, Zarei M, Vaez-Gharamaleki Y. Formulating research questions for evidence-based studies. J Med Surg Public Health. 2024;2:100046–100046. doi: 10.1016/j.glmedi.2023.100046. - DOI

MeSH terms